Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
TB-500 structure

TB-500

Healing & Recovery
Phase 2 Research
40%
Low-Moderate Risk
2/5

Dosing Protocol

Typical Dose 5 mg
Range 2 - 10 mg
Loading Phase 5 mg × 28 days
Maintenance 2.5 mg weekly

Pharmacokinetics

Half-Life 2.0 hrs
Onset 30 min
Peak 1.0 hrs
Duration 1.0 days
Bioavailability 75%
Primary Route Subcutaneous

Administration

Routes Subcutaneous, Intramuscular
Injection Sites Abdomen, Thigh, Deltoid
Needle Gauge 29-31G
Syringe Type Insulin
Timing Morning, Post-Workout

Reconstitution

Diluent Bacteriostatic Water
Volume 3 mL
Concentration 3333 mcg/mL
Stability 42 days refrigerated
Vial Sizes 5, 10 mg

Special Instructions

Loading phase: 4-8mg/week for first 4 weeks. Maintenance: 2-4mg every 1-2 weeks.